In what appears to be a significant reorganization, Gary Reedy, CEO of the American Cancer Society, announced to the staff of the Atlanta-based charity that he will be stepping away from its day-to-day operations.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
